Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SZT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HIRIP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DDX27 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMD13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AFG3L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LAMB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SMARCA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDK10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPKOW - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DPH7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
INTS10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANXA9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLEC4A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AUP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL58 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SDHA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on